Projects funded by the NCN
Analysis of pharmacokinetic, pharmacodynamic and molecular determinants of intolerance and resistance to the Janus kinase inhibitor ruxolitinib in pediatric patients
2024/53/B/NZ7/01110
Keywords:
tyrosine kinase inhibitor Graft-versus-Host Disease HPLC-MS/MS genetic polymorphism
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
woj.
Principal investigator (from the host institution):
dr hab. Marta Karaźniewicz-Łada
Number of co-investigators in the project: 10
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 2 017 824 PLN
Project start date (Y-m-d): 2025-02-20
Project end date (Y-m-d): 2029-02-19
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.